rosiglitazone has been researched along with Adrenal Cortex Cancer in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantini, G; Ercolino, T; Francalanci, M; Gelmini, S; Lombardi, A; Luconi, M; Mangoni, M; Mannelli, M; Nesi, G; Orlando, C; Pepi, M; Poli, G; Pratesi, N; Serio, M | 1 |
Amendola, D; Bucci, B; Cerquetti, L; De Venanzi, A; Marchese, R; Masuelli, L; Misiti, S; Poggi, M; Sampaoli, C; Stigliano, A; Toscano, V | 1 |
Ceni, E; Ferruzzi, P; Fiorelli, G; Galli, A; Grappone, C; Mannelli, M; Milani, S; Serio, M; Tarocchi, M | 1 |
Betz, MJ; Beuschlein, F; Fassnacht, M; Hahner, S; Reincke, M; Shapiro, I | 1 |
4 other study(ies) available for rosiglitazone and Adrenal Cortex Cancer
Article | Year |
---|---|
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model.
Topics: Adrenal Cortex Neoplasms; Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Mice; Mice, Nude; Rosiglitazone; Thiazolidinediones; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells.
Topics: Adrenal Cortex Neoplasms; Apoptosis; Autophagy; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin E; Fluorescent Antibody Technique; Humans; Hypoglycemic Agents; Membrane Potential, Mitochondrial; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones | 2011 |
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Cell Division; Cell Line, Tumor; Female; Humans; Hypoglycemic Agents; Matrix Metalloproteinase 2; Middle Aged; Neoplasm Invasiveness; Pioglitazone; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured | 2005 |
Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Anilides; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin E; Dose-Response Relationship, Drug; Female; Humans; Insulin-Like Growth Factor II; Male; Middle Aged; PPAR gamma; Promoter Regions, Genetic; Receptor, Melanocortin, Type 2; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2005 |